1130798

Philip NMI Raskin — FEI 3008281994

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 4, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Dallas, TX (United States)

Additional Details

Clinical Investigator (CI)